mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |